CLL’s anti-inflammatory properties have been related to HMGB1 (high mobility group box 1) functions, such molecule originating in necrotic and inflammatory cells and displaying pro-inflammatory mediator properties [5]. This evidence concerns the gene HMGB1 and B-cell chronic lymphocytic leukemia.